Bionano genomics, inc (BNGO)
CashFlow / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Operating activities:
Net loss

-7,900

-6,398

-7,664

-7,851

-6,411

-4,926

-3,311

-3,847

Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization expense

312

278

266

269

150

391

387

391

Change in fair value of preferred stock warrants and expirations

0

0

0

0

0

-1,520

-1,517

-953

Stock-based compensation

356

364

335

289

1,033

53

52

54

Accretion of debt discount

-

-75

-79

-49

-

-61

-39

-21

Loss on debt extinguishment

-412

0

0

-921

0

0

-342

0

Long-term debt prepayment fees

-

0

0

412

-

-

-

0

Changes in operating assets and liabilities:
Accounts receivable

888

1,017

926

-457

513

614

588

-816

Inventory

1,754

-67

1,616

337

-1,682

1,928

-147

320

Prepaid expenses and other current assets

343

189

-1,088

801

-428

-421

23

673

Accounts payable

320

-1,215

2,767

-510

-1,015

1,119

297

-1,355

Accrued expenses and contract liabilities

-411

704

-918

550

-353

57

970

-920

Net Cash Provided by (Used in) Operating Activities

-9,454

-7,176

-6,317

-6,551

-4,090

-6,099

-2,966

-6,787

Investing activities:
Purchases of property and equipment

22

8

29

0

11

130

177

11

Net cash used in investing activities

-22

-8

-29

0

-11

-130

-177

-11

Financing activities:
Proceeds from issuance of long-term debt, net of issuance costs

-

-37

0

19,207

-

-129

9,662

0

Proceeds from borrowing from line of credit

5,113

0

0

0

-14,329

0

1,000

13,329

Repayment of long-term debt

0

0

0

10,812

0

0

7,447

0

Proceeds from issuance of common stock, net of issuance costs

-

-

-

2,409

-

-

-

0

Proceeds from option exercises

-

0

11

53

-

2

0

0

Net cash provided by financing activities

18,593

115

810

10,858

-32

19,262

3,215

13,330

Net increase in cash and cash equivalents

9,086

-7,069

-5,535

4,307

-4,134

13,032

71

6,530

Supplemental disclosure of non-cash financing and investing activity:
Fair value of warrants issued with debt classified as a liability

-

0

0

629

-

0

176

0

Transfer of instruments and servers from inventory into property and equipment

906

359

-29

29

0

-106

106

0

Final payment fee due in connection with the repayment of debt classified within other long-term liabilities

0

0

-201

201

0

0

400

0

Loan amendment fee due in connection with the repayment of debt classified within current liabilities

-

-

-

0

-

-

-

70